Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
33.40
+0.35 (1.06%)
Mar 4, 2026, 12:26 PM EST - Market open
Galapagos NV Employees
Galapagos NV had 558 employees as of June 30, 2025.
Employees
558
Change
n/a
Growth
n/a
Revenue / Employee
$2,340,350
Profits / Employee
$675,192
Market Cap
2.17B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,869 |
| Ultragenyx Pharmaceutical | 1,371 |
| Telix Pharmaceuticals | 1,184 |
| Ascentage Pharma Group International | 605 |
| Ocular Therapeutix | 325 |
| Immunome | 168 |
| Soleno Therapeutics | 152 |
| Stoke Therapeutics | 128 |
GLPG News
- 1 day ago - Galapagos NV at TD Cowen Healthcare Conference Transcript - GuruFocus
- 6 days ago - Galapagos FY25: Profits Not Built On Product - Seeking Alpha
- 7 days ago - GLPG: RBC Capital Raises Price Target, Reaffirms Sector Perform | GLPG Stock News - GuruFocus
- 7 days ago - Galapagos NV (GLPG) Full Year 2025 Earnings Call Highlights: Strategic Shifts and Financial ... - GuruFocus
- 7 days ago - Galapagos NV (GLPG) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Full Year 2025 Galapagos NV Earnings Call Transcript - GuruFocus
- 8 days ago - Galapagos GAAP EPS of €4.87, revenue of €1.11B; introduces Q1 and FY26 outlook - Seeking Alpha
- 8 days ago - Earnings Breakdown: Galapagos Q4 - Benzinga